Venus Remedies secures marketing authorization from UK MHRA for Cisplatin
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Apollo continues to invest in genomics technology and research for better patient care
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Gafchromic films support patient care in oncology
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Subscribe To Our Newsletter & Stay Updated